Furthermore, an analysis of PD‐L1 expression and T‐cell–inflamed GEP in tumor samples from pembrolizumab‐treated patients with 20 different types of locally advanced or metastatic solid cancers, including EC, has demonstrated greater response in tumors with higher PD‐L1 expression and with higher T‐cell–inflamed GEP.15 Here, CD274 is linked to neoplasm.